Evidence map›Paper›PMID 26085818›Full record

ArticleJournal of carcinogenesis2015

Single nucleotide polymorphisms in CRTC1 and BARX1 are associated with esophageal adenocarcinoma.

Anna M J van Nistelrooij, Hetty A G M van der Korput, Linda Broer, Ronald van Marion, Mark I van Berge Henegouwen, Carel J van Noesel, Katharina Biermann, Manon C W Spaander, Hugo W Tilanus, J Jan B van Lanschot and 4 more

Open access · goldAbstract read
In one paragraph

Article in Journal of carcinogenesis, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Anna M J van NistelrooijDepartment of Pathology, Erasmus MC Cancer Institute, University Medical Centre, Rotterdam, The Netherlands ; Department of Surgery, Erasmus MC Cancer Institute, University Medical Centre, Rotterdam, The Netherlands.
Hetty A G M van der KorputDepartment of Pathology, Erasmus MC Cancer Institute, University Medical Centre, Rotterdam, The Netherlands.
Linda BroerDepartment of Internal Medicine, Erasmus MC Cancer Institute, University Medical Centre, Rotterdam, The Netherlands.
Ronald van MarionDepartment of Pathology, Erasmus MC Cancer Institute, University Medical Centre, Rotterdam, The Netherlands.
Mark I van Berge HenegouwenDepartment of Surgery, Academic Medical Centre, Amsterdam, The Netherlands.
Carel J van NoeselDepartment of Pathology, Academic Medical Centre, Amsterdam, The Netherlands.
Katharina BiermannDepartment of Pathology, Erasmus MC Cancer Institute, University Medical Centre, Rotterdam, The Netherlands.
Manon C W SpaanderDepartment of Gastroenterology and Hepatology, Erasmus MC Cancer Institute, University Medical Centre, Rotterdam, The Netherlands.
Hugo W TilanusDepartment of Surgery, Erasmus MC Cancer Institute, University Medical Centre, Rotterdam, The Netherlands.
J Jan B van LanschotDepartment of Surgery, Erasmus MC Cancer Institute, University Medical Centre, Rotterdam, The Netherlands.
Albert HofmanDepartment of Epidemiology, Erasmus MC Cancer Institute, University Medical Centre, Rotterdam, The Netherlands.
André G UitterlindenDepartment of Internal Medicine, Erasmus MC Cancer Institute, University Medical Centre, Rotterdam, The Netherlands ; Department of Epidemiology, Erasmus MC Cancer Institute, University Medical Centre, Rotterdam, The Netherlands.
Bas P L WijnhovenDepartment of Surgery, Erasmus MC Cancer Institute, University Medical Centre, Rotterdam, The Netherlands.
Winand N M DinjensDepartment of Pathology, Erasmus MC Cancer Institute, University Medical Centre, Rotterdam, The Netherlands.
Erasmus MC Cancer Institute · NLAmsterdam UMC Location University of Amsterdam · NLErasmus University Rotterdam · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveRecently, single nucleotide polymorphisms (SNPs) associated with esophageal adenocarcinoma (EAC) and Barrett's esophagus (BE) were identified; rs10419226 (CRTC1), rs11789015 (BARX1), rs2687201 (FOXP1), rs2178146 (FOXF1), rs3111601 (FOXF1), and rs9936833 (FOXF1). These findings indicate that genetic susceptibility could play a role in the initiation of EAC in BE patients. The aim of this study was to validate the association between these previously identified SNPs and the risk of EAC in an independent and large case-control study.

designSix SNPs found to be associated with EAC and BE were genotyped by a multiplex SNaPshot analysis in 1071 EAC patients diagnosed and treated in the Netherlands. Allele frequencies were compared to a control group derived from the Rotterdam Study, a population-based prospective cohort study (n = 6206). Logistic regression analysis and meta-analysis were performed to calculate odds ratios (OR).

resultsRs10419226 (CRTC1) showed a significantly increased EAC risk for the minor allele (OR = 1.17, P = 0.001), and rs11789015 (BARX1) showed a significantly decreased risk for the minor allele (OR = 0.85, P = 0.004) in the logistic regression analysis. The meta-analysis of the original GWAS and the current study revealed an improved level of significance for rs10419226 (CRTC1) (OR = 1.18, P = 6.66 × 10(-10)) and rs11789015 (BARX1) (OR = 0.83, P = 1.13 × 10(-8)).

conclusionsThis independent and large Dutch case-control study confirms the association of rs10419226 (CRTC1) and rs11789015 (BARX1) with the risk of EAC. These findings suggest a contribution of the patient genetic make-up to the development of EAC and might contribute to gain more insight in the etiology of this cancer.

Indexed as

Barrett's esophagusesophageal adenocarcinomasingle nucleotide polymorphisms

Identifiers

PMID26085818
PMCPMC4453126
OpenAlexW1803965125

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.